Persisting challenges in the early detection of hepatocellular carcinoma Ashwini Arvind, Kennedy Redmon, Amit G Singal Expert Review of Anticancer Therapy.2025; 25(3): 229. CrossRef
Exosomal FOSL1 From Cancer-associated Fibroblasts Drives the Progression and Pro-tumorigenic M2 Macrophage Polarization of Hepatocellular Carcinoma By Activating PLAU Transcription Kai Bai, Ruopeng Liang, Jian Li, Kun Zhao Applied Biochemistry and Biotechnology.2026; 198(2): 822. CrossRef
Development of an UPLC-MS/MS method for quantification of donafenib and its metabolite in rat plasma: application to drug–drug interaction Yuxin Shen, Ruibin Li, Lu Cao, Jun Wu, Haoxin Fu, Peiqi Wang, Ren-ai Xu, Ling Ji Biochemical Pharmacology.2026; 246: 117540. CrossRef
Comparison of repeat hepatectomy with radiofrequency ablation for the survival of hepatocellular carcinoma with solitary intrahepatic recurrence after hepatectomy Jialu Fu, Jiafeng Chen, Lei Jin, Junfeng Huang, Shengwei Mao, Xuhui Zhao, Weifeng Qu, Rui Yang, Yi Wang, Yichao Bu, Zhiqi Guan, Jun Gao, Xiaoling Wu, Qianfu Zhao, Tianhao Chu, Guiqi Zhu, Yuan Fang, Yinghong Shi, Weiren Liu Clinics and Research in Hepatology and Gastroenterology.2026; 50(2): 102750. CrossRef
Management and outcomes of patients with liver cancer in China and the United States Mengyuan Xu, Qiushuo Geng, Tianhao Shan, Manqi Liu, Jianguo Chen, Meicen Liu, Bingfeng Han, Changfa Xia, Xianhui Ran, Kexin Sun, Shaoming Wang, Yubing Shen, Ru Chen, Li Li, Hong Zhao, Wanqing Chen, Lingeng Lu, Yefan Zhang, Hongmei Zeng Chinese Medical Journal.2026; 139(10): 1502. CrossRef
TRIM13 Suppressed the Proliferation and Migration of Hepatocellular Carcinoma Cells by Inducing Autophagy Longxu Jiang, Danghui Lu, Kristian Holgersson, Shan Zhang, Guangyan Shi, Laszlo Szekely, Xue Bai, Yuanpeng Zhai, Xinju Chen, Takahiro Seki, Kun Li Journal of Biochemical and Molecular Toxicology.2026;[Epub] CrossRef
Research on Anti-tumor Pharmacodynamics of Multi-functional Magnetic Lipid Polymer with Specific Targeted Transmission of siRNA and its Toxicity Evaluation Yaru Liu, Chang Wang, Jie Jin, Jishan Quan, Guangyu Jin Current Pharmaceutical Design.2026; 32(19): 1524. CrossRef
Association Between Multi‐Laboratory Parameters Pre‐ and Post‐Treatment and Pathological Features and Their Values in Clinical Decision in Primary Hepatic Carcinoma Xiaowei Chi, Weifang Liu, Zihan Liu, Jie Liu Journal of Clinical Laboratory Analysis.2026;[Epub] CrossRef
ENPP2 Dysregulation Defines a Candidate Biomarker Axis Coupling Tumor‐Intrinsic cAMP Signaling to Macrophage Polarization in Hepatocellular Carcinoma Shiyi Chen, Jinli Zheng, Jianwu Long, Peng Ou, Jian Tong, Fan Lin, Shaoqiu Chen Human Mutation.2026;[Epub] CrossRef
SF3B4 stabilizes SREBF1 via 3′UTR binding to drive hepatocellular carcinoma progression Yuan Fang, Dan Wang, Lei Han, Mengge Li, Qiuyue He, WangGan Xu, HaiJing Li, Zhong Zeng, Jie Lin, HanFei Huang Frontiers in Oncology.2026;[Epub] CrossRef
Comprehensive characterization of SLC41A3 identifies it as an immune-related prognostic biomarker and therapeutic target in hepatocellular carcinoma Biyan Gong, Dunfu Cao, Shidong Hu, Xiangyi Zhou, Leida Zhang, Fengsheng Dai, Jianheng Peng Frontiers in Immunology.2026;[Epub] CrossRef
Quercetin, an ingredient of Jiedu Xiaozheng Yin, alleviates hepatocellular carcinoma progression by regulating CYP1A2/PTEN/PI3K/Akt axis Zhenhua Zhou, Zhenliang Xiao, Wu Wen, Yongkang Zhu In Vitro Cellular & Developmental Biology - Animal.2026;[Epub] CrossRef
Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma Weibin Zhang, Jia Dong, Yunfei Wu, Xiangnan Liang, Lida Suo, Liming Wang Biochemical Genetics.2025; 63(3): 2650. CrossRef
Exploring the association between air pollution and the incidence of liver cancers Xin Wu, Xin Zhang, Xiaopeng Yu, Hongyuan Liang, Shaoshan Tang, Yao Wang Ecotoxicology and Environmental Safety.2025; 290: 117437. CrossRef
α-Fetoprotein model versus Milan criteria in predicting outcomes after hepatic resection for hepatocellular carcinoma: multicentre study Chao Li, Yong-Kang Diao, Yi-Fan Li, Shao-Dong Lv, Xian-Ming Wang, Xue-Dong Wang, Qi-Xuan Zheng, Hong Wang, Han Liu, Kong-Ying Lin, Ying-Jian Liang, Ya-Hao Zhou, Wei-Min Gu, Ming-Da Wang, Lan-Qing Yao, Xin-Fei Xu, Jia-Hao Xu, Li-Hui Gu, Timothy M Pawlik, F BJS Open.2025;[Epub] CrossRef
METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery Xie Weng, Yangyue Huang, Zhuoya Fu, Xingli Liu, Fuli Xie, Jiale Wang, Qiaohua Zhu, Dayong Zheng Frontiers in Immunology.2025;[Epub] CrossRef
MSNs-loaded HMME and Erastin-mediated ferroptosis combined with sonodynamic therapy for HCC treatment Chang Zhao, Guchun Qin, Caixia Ling, Yang Zhao, Yunxi Huang, Zelong Jiang, Niqiang Zhou, Junjie Liu, Danke Su, Jinghang Jiang Journal of Cancer Research and Therapeutics.2025; 21(2): 465. CrossRef
SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming Xin Jin, Xigan He, Runze Huang, Qinyu Liu, Lei Wang, Xuanci Bai, Yibin Wu, Yixiu Wang, Ziting Jiang, Yi Shi, Gautam Sethi, Lu Wang, Weiping Zhu Journal of Experimental & Clinical Cancer Research.2025;[Epub] CrossRef
Preoperative ASAP score predicts recurrence and survival following curative hepatic resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter cohort study Dongxu Yin, Zixuan Wang, Chao Li, Huixuan Fan, Zichao Tu, Yongkang Diao, Zijie Tang, Yongyi Zeng, Han Wu, Lihui Gu, Lanqing Yao, Xinfei Xu, Feng Shen, Mingda Wang, Tian Yang European Journal of Surgical Oncology.2025; 51(10): 110361. CrossRef
Artificial intelligence for enhancing decision-making in multidisciplinary tumor boards for HCC in China Dong Li, Haoyu Wang, Fei Gao, Xifeng Fu, Junfeng Han Hepatoma Research.2025;[Epub] CrossRef
Predictive indicators of immune therapy efficacy in hepatocellular carcinoma based on neutrophil-to-lymphocyte ratio Shengzhe Lin, Yang Wang, Xinran Cai, Yunbin Ye, Yanling Chen International Immunopharmacology.2024; 128: 111477. CrossRef
Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma Ming-Da Wang, Yong-Kang Diao, Lan-Qing Yao, Zhong-Qi Fan, Ke-Chun Wang, Han Wu, Li-Hui Gu, Jia-Hao Xu, Chao Li, Guo-Yue Lv, Tian Yang iLIVER.2024; 3(1): 100083. CrossRef
Cell-Membrane-Coated Metal–Organic Framework Nanocarrier Combining Chemodynamic Therapy for the Inhibition of Hepatocellular Carcinoma Proliferation Huaying Xie, Xuhua Xiao, Xiaoyuan Yi, Kunzhao Huang, Liyan Wang Pharmaceutics.2024; 16(5): 619. CrossRef
Apolipoprotein H-based prognostic risk correlates with liver lipid metabolism disorder in patients with HBV-related hepatocellular carcinoma Yaming Liu, Zeyi Wu, Yiqun Zhao, Maochuan Zhen, Yanhong Wang, Qiusong Liu Heliyon.2024; 10(10): e31412. CrossRef
Clinical significance of LINC02532 in hepatitis B virus-associated hepatocellular carcinoma and its regulatory effect on tumor progression Wei Ding, Sujuan Xi, Kewei Gao, Danping Weng, Sheng Xu, Guoping Huang, Min Yu, Haiyan Yue, Jianguo Wang Clinics and Research in Hepatology and Gastroenterology.2024; 48(7): 102403. CrossRef
First
Prev
